Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

DMC Heart Hospital Offers First-Of-Its-Kind Naturally Dissolving Heart Stent For Coronary Artery Disease

Aug 16, 2016

Recently approved by FDA, Absorb™ bioresorbable vascular scaffold opens

The interventional cardiology team at Detroit Medical Center’s (DMC) Heart Hospital 800_absorbinflatedcurveap2942720revarecently became one of the first in Michigan to offer patients with coronary artery disease a new treatment option that literally disappears over time.

A team composed of Dr. Theodore Schreiber, Dr. Cindy Grines, Dr. Mahir Elder, Dr. Amir Kaki and Dr. Tamam Mohamad implanted a patient on July 11, 2016 with the world's first FDA-approved dissolving heart stent. The Absorb™ bioresorbable vascular scaffold, manufactured by Abbott, is an advance in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide despite decades of therapeutic advances.

While stents are traditionally made of metal, the Absorb™ stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb™ disappears in about three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants.

“The benefit of a bioresorbable stent comes from not implanting a permanent metal prosthesis,” explained Dr. Kaki, medical director of the Cardiac Catheterization Laboratories at DMC Heart Hospital. “After it has dissolved, the patient’s artery is restored to a natural state.”

DMC Heart Hospital President Dr. Theodore Schreiber stressed the forward-thinking that led to providing this innovation at DMC. “Our goal is to provide next-level care in every aspect – technically, clinically, and personally. This new technology is an excellent example of our ‘never settle for the status quo’ mindset.”

To ensure optimal patient selection and implant technique, DMC Heart Hospital’s interventional cardiology team underwent extensive training on the new device.

More information about heart stents is available online at www.dmc.org/Stent101/.

Find a Doctor

Need a doctor for your care?
 

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.